Investing.com -- Shares of Teladoc Health Inc (NYSE: NYSE:TDOC) climbed 6% after Citron Research, led by notable short seller Andrew Left, highlighted the company's potential in a recent report.

Investing.com -- Shares of Teladoc Health Inc (NYSE: NYSE:TDOC) climbed 6% after Citron Research, led by notable short seller Andrew Left, highlighted the company's potential in a recent report.

Shares of telemedicine company Teladoc Health (NYSE: TDOC) surprisingly popped on Thursday after Citron Research gave it a glowing recommendation. As of 3:30 p.m. ET, Teladoc stock was up 7% ...

Teledoc (TDOC), which just acquired Catapult Health, is using technology the “right” way, by cutting costs, improving care, and expanding margins, all while making money, Citron Research says ...

This is why the shoutout from Citron Research was so surprising. The research firm has a large social media presence and called Teladoc "The Under-the-Radar AI Play," which is attention grabbing.

Novavax (NVAX) closed the most recent trading day at ... outlook on the company's business health and profitability. Our research suggests that these changes in estimates have a direct ...